Showing 4601-4610 of 23276 results for "".
Face Value with Modern Aesthetics: Secrets to a Snatched Neck
https://reachmd.com/series/face-value/face-value-with-modern-aesthetics-secrets-to-a-snatched-neck/39891/Anil Shah, MD, FACS, explains how he is changing the way clinicians think about neck contour and jawline procedures with his innovative 5 layer neck technique.Growth & Nutritional Supplements for Skin, Hair, and More
https://reachmd.com/programs/practical-dermatology/tbd/39742/Glynis Ablon, MD, reviews evidence and clinical perspectives on growth and nutritional supplements for skin and hair health. This video was recorded at the Science of Skin Summit in Austin, TX.New Devices and Adaptogens
https://reachmd.com/conferences/science-of-skin-summit-2025/tbd/39741/Jacqueline Watchmaker, MD, explores the intersection of medical devices and adaptogenic therapies in skincare. This video was recorded at the Science of Skin Summit in Austin, TX.Face Value with Modern Aesthetics: Dr. Alexander Rivkin Shares Findings on BOTOX for Masseter Muscles
https://reachmd.com/series/face-value/face-value-with-modern-aesthetics-dr-alexander-rivkin-shares-findings-on-botox-for-masseter-muscles/39773/Alexander Rivkin, MD, discusses a groundbreaking Phase 2B clinical study he co-authored earlier this year that investigated the use of Onabotulinumtoxin-A for the treatment of masseter muscle prominence.Vutrisiran for ATTR-CM: Impacts on Functional Capacity and Quality of Life
https://reachmd.com/programs/on-the-frontlines-of-attr-cm/vutrisiran-for-attr-cm-impacts-on-functional-capacity-and-quality-of-life/39314/When evaluating treatment options for patients with transthyretin amyloidosis with cardiomyopathy (ATTR-CM), functional capacity and quality of life are crucial to take into account. That's why the HELIOS-B trial, published in the Journal of the American College of Cardiology in May 2025, assessed tIncreased APS Risk for Psoriasis Patients, Plus More
https://reachmd.com/series/dermwire-tv/increased-aps-risk-for-psoriasis-patients-plus-more/39299/This episode highlights research showing increased risk for anti-phospholipid syndrome (APS) in patients with psoriatic disease, as well as research showing increased risks for tuberculosis in patients treated with immunosuppressants. The episode also features a clip from an in-depth discussion arouBiologics Preferred after MACE in PsO, Plus More
https://reachmd.com/series/dermwire-tv/biologics-preferred-after-mace-in-pso-plus-more/37882/In this edition of DermwireTV, new research shows biologic use use after MACE is persistent, signaling strong patient preference; a new study shows that early stress may raise lifelong psoriasis risk; and a new C-Suite Chat highlights a new antibody showing promise in treating atopic dermatitisAddressing Pediatric Flu Burden: The Critical Role of Vaccination
https://reachmd.com/programs/vaccination/addressing-pediatric-flu-burden-the-critical-role-of-vaccination/36266/Pediatric influenza remains a serious threat, with the 2024-2025 season bringing one of the highest recorded pediatric mortality rates in over a decade. As a result, understanding barriers to vaccine uptake and implementing strategies to address them is critical. Joining Dr. Charles Turck to provideClosing Care Gaps and Addressing Unmet Needs in SMA
https://reachmd.com/programs/neurofrontiers/closing-care-gaps-and-addressing-unmet-needs-in-sma/36617/Given the prevalence of spinal muscular atrophy (SMA), why are there so many barriers to care? To answer this question, Dr. Jennifer Kwon explores unmet patient needs, the role of disease-modifying therapy in treatment, and strategies to overcome obstacles to care.AI for Patient Education and More
https://reachmd.com/series/c-suite-chats/ai-for-patient-education-and-more/36239/Anastasia Georgievskaya, founder of Haut.AI, discusses the impact of new artificial intelligence tools such as a virtual skincare try-on that shows customers how sunscreen and its ingredients will impact skin over time.